Acadia Healthcare (NASDAQ:ACHC) Updates FY 2026 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.450-1.600 for the period, compared to the consensus estimate of 1.510. The company issued revenue guidance of $3.4 billion-$3.5 billion, compared to the consensus revenue estimate of $3.4 billion.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several research analyst reports. TD Cowen boosted their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. UBS Group lifted their target price on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Barclays increased their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Finally, Royal Bank Of Canada upped their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $28.69.

Acadia Healthcare Stock Performance

ACHC traded up $0.19 on Tuesday, reaching $32.69. The stock had a trading volume of 4,238,779 shares, compared to its average volume of 3,332,939. The business’s 50-day moving average price is $27.78 and its two-hundred day moving average price is $23.36. The company has a market cap of $3.01 billion, a P/E ratio of -2.67, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same period in the prior year, the company posted $0.40 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts forecast that Acadia Healthcare will post 1.5 earnings per share for the current year.

Institutional Trading of Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Acadia Healthcare during the 1st quarter worth approximately $1,600,000. Goldman Sachs Group Inc. increased its holdings in Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after acquiring an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after buying an additional 27,207 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Acadia Healthcare by 531.5% during the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after acquiring an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. boosted its stake in shares of Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after acquiring an additional 1,780 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.